Author | Henry M. Kuerer, MD, PhD | OncLive

Author | Henry M. Kuerer, MD, PhD

Articles

Testing the Power of Neoadjuvant Systemic Therapy in Breast Cancer

March 13, 2018

Article

Neoadjuvant therapy can eliminate both invasive and in situ carcinoma in up to 50% of patients, particularly when their subtypes are triple-negative disease or HER2-positive cancers.

Dr. Kuerer on Margins of DCIS

August 10, 2017

Video

Henry M. Kuerer, MD, PhD, professor of surgery, The University of Texas MD Anderson Cancer Center, discusses margins of ductal carcinoma in situ (DCIS).

Dr. Kuerer on Eliminating Breast Cancer Surgery

January 25, 2017

Video

Henry M. Kuerer, MD, PhD, professor of Surgery, The University of Texas MD Anderson Cancer Center, discusses the elimination of breast cancer surgery in exceptional responders.

Dr. Kuerer on De-Escalating Surgery in the Treatment of Patients With Breast Cancer

August 05, 2016

Video

Henry M. Kuerer, MD, PhD, professor of Surgery, PH and Fay Etta Robinson Distinguished Professor in Research, Breast Surgical Oncology, executive director, Breast Programs, director, Breast Surgical Oncology Fellowship Training Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses de-escalating surgery in the treatment of patients with breast cancer.

x